Company

xForest Therapeutics Co., Ltd.

xForest Therapeutics develops small molecule drugs targeting disease-related RNA.

About

xForest Therapeutics develops small molecule therapeutics targeting disease-related RNA using its FOREST platform. Founded in 2020 and based in Kyoto-shi, Japan, it raised JPY 133.277 mn in a Seed round on January 24, 2025, with Miyako Capital, KSP, and returning investor ANRI participating.

2Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in